Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis
Clinical trial NCT02781558 · COMPLETED
Trial details
- NCT number
- NCT02781558
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-29
- Primary completion
- 2017-10-06
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.